Nosebleed drug could be crash saviour

Updated on Mar 23, 2011 11:58 PM IST

Giving tranexamic acid, an anti-fibrinolytic drug used to stop nosebleeds, within three to eight hours of injury can save the life of 12,500 of the 85,000 people who bleed to death in road traffic accidents in India each year, reports a study in The Lancet.

HT Image
HT Image
Hindustan Times | By, New Delhi

Giving tranexamic acid, an anti-fibrinolytic drug used to stop nosebleeds, within three to eight hours of injury can save the life of 12,500 of the 85,000 people who bleed to death in road traffic accidents in India each year, reports a study in The Lancet.

Over 4,760 patients and their families from 84 hospitals across India participated in this study, which involved 20,211 accident victims across 40 countries.

Road traffic accidents — and not AIDS, cancer, malaria or any other disease — are the leading cause of death among young people between 10 and 24 years, according to the World Health Organisation (WHO). Of the 1.2 million road accident deaths each year, nearly 400,000 victims are under the age of 25.

“The drug is very cheap and easily available throughout the country...,” said Dr Yashbir Dewan, lead coordinator for the study.

SHARE THIS ARTICLE ON
  • ABOUT THE AUTHOR

    Sanchita is the health & science editor of the Hindustan Times. She has been reporting and writing on public health policy, health and nutrition for close to two decades. She is an International Reporting Project fellow from Paul H. Nitze School of Advanced International Studies at the Bloomberg School of Public Health and was part of the expert group that drafted the Press Council of India’s media guidelines on health reporting, including reporting on people living with HIV.

SHARE
Story Saved
×
Saved Articles
Following
My Reads
My Offers
Sign out
New Delhi 0C
Thursday, December 01, 2022
Start 15 Days Free Trial Subscribe Now
Register Free and get Exciting Deals